To The Honorable Seema Verma, Administrator, Centers for Medicare & Medicaid Services:
“The Endocrine Society is pleased to offer the following comments on the revisions to the classification and payment for continuous glucose monitors (CGM) under Medicare Part B in the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) proposed rule. Founded in 1916, the Society represents approximately 18,000 physicians and scientists engaged in the treatment and research of all endocrine disorders, including diabetes. Our members are leaders in the treatment of diabetes and have authored Society clinical practice guidelines in diabetes technology, diabetes and pregnancy, and treatment of diabetes in older adults. As such, our members are knowledgeable about the challenges patients with diabetes face controlling their condition and have found that various types of diabetes technology have significantly improved the quality of their lives."
Read the Full Letter